Blossom Gold Announces Selection of Kappes, Cassiday and Associates as Lead for Rosebud's Feasibility, the Rosebud Technical Team and Provides an Update on Permitting Activities Supporting a 2029 Start of Construction

Blossom Gold appointed Kappes, Cassiday & Associates as lead consultant for the feasibility study of its Rosebud open-pit project in Nevada. The study is expected to begin in Q2 2027 after an updated mineral resource estimate is delivered by the end of Q1 2027; permitting work is progressing toward a target of advancing the project to construction by 2029.

Analysis

This is a process milestone, not evidence that Rosebud is economic or construction-ready. Naming a feasibility-study consultant may modestly reduce execution uncertainty, but it does not resolve the value drivers investors need: updated resource scale and grade, recoveries, capex/opex, permitting conditions, and financing. The key near-term risk is schedule slippage between the updated resource estimate, the feasibility study, and the environmental review; delay would defer any credible construction decision and could raise funding needs before project-level cash flow exists.

Over the next 1–3 months, the announcement alone is unlikely to establish a durable valuation floor. The more consequential checkpoints are the planned resource update at end-Q1 2027 and study commencement in Q2 2027. Over 6–18 months, gold-price sensitivity and the feasibility study’s capital intensity will determine whether Rosebud competes for investor and lender capital against other development projects. The stated 2029 construction objective remains a company schedule, not an independently confirmed outcome.

Contrarian angle: market attention may overvalue visible permitting progress while underweighting the risk that resource revisions or study economics weaken the project. Conversely, if gold remains supportive and the resource update is robust, sequential technical de-risking could attract specialist developer capital—but the article provides no economics to underwrite that case.

Key Decisions for Investors

• No directional trade on this announcement alone; treat the consultant appointment as a limited de-risking signal, not a feasibility or financing milestone.
• Add Blossom Gold to a catalyst watchlist for the end-Q1 2027 resource update and Q2 2027 feasibility-study start. Verify resource changes, recovery assumptions, capex/opex, permitting milestones, and funding runway before sizing exposure.
• For gold exposure, prefer liquid bullion-linked exposure over treating this project update as a substitute for gold-price sensitivity; reassess only if Rosebud publishes supportable economics and a credible funding path.
• Falsification of the constructive de-risking thesis: a delayed resource update or study start, adverse EIS developments, materially weaker project economics, or financing terms that imply substantial dilution.